- Home
- MTC vs ADAG Comparison
MTC vs ADAG Comparison
Compare MTC & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTC | ADAG |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | Hong Kong | China |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.8M | 84.8M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MTC | ADAG |
|---|---|---|
| Price | $2.49 | $1.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 3.1M | 98.5K |
| Earning Date | 12-12-2025 | 08-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,675,833.00 | $103,204.00 |
| Revenue This Year | N/A | $6,983.06 |
| Revenue Next Year | N/A | $36.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 114.77 | N/A |
| 52 Week Low | $0.25 | $1.30 |
| 52 Week High | $3.89 | $3.16 |
Technical Indicators
Market Signals| Indicator | MTC | ADAG |
|---|---|---|
| Relative Strength Index (RSI) | 57.27 | 54.52 |
| Support Level | $2.41 | $1.92 |
| Resistance Level | $2.94 | $2.06 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 57.55 | 62.50 |
Price Performance
Historical ComparisonAbout MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.